Current status of the chemotherapy of tuberculosis. Part II.
D004977:Ethambutol / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects / Q000627:therapeutic use; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000517:prevention & control
D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin